Primary and Metastatic Brain Tumours Assessed with the Brain and Torso [<sup>18</sup>F]FDG PET/CT Study Protocol—10 Years of Single-Institutional Experiences

Agata Pietrzak; Andrzej Marszałek; Tomasz Piotrowski; Adrianna Medak; Katarzyna Pietrasz; Julia Wojtowicz; Hubert Szweda; Krzysztof Matuszewski; Witold Cholewiński

doi:10.3390/ph14080722

Pharmaceuticals (Jul 2021)

Primary and Metastatic Brain Tumours Assessed with the Brain and Torso [<sup>18</sup>F]FDG PET/CT Study Protocol—10 Years of Single-Institutional Experiences

Agata Pietrzak,
Andrzej Marszałek,
Tomasz Piotrowski,
Adrianna Medak,
Katarzyna Pietrasz,
Julia Wojtowicz,
Hubert Szweda,
Krzysztof Matuszewski,
Witold Cholewiński

Affiliations

Agata Pietrzak: Electroradiology Department, Poznan University of Medical Sciences, 61-866 Poznan, Poland
Andrzej Marszałek: Oncologic Pathology and Prophylaxis Department, Poznan University of Medical Sciences and Greater Poland Cancer Center, 61-866 Poznan, Poland
Tomasz Piotrowski: Electroradiology Department, Poznan University of Medical Sciences, 61-866 Poznan, Poland
Adrianna Medak: Electroradiology Department, Poznan University of Medical Sciences, 61-866 Poznan, Poland
Katarzyna Pietrasz: Nuclear Medicine Department, Greater Poland Cancer Centre, 61-866 Poznan, Poland
Julia Wojtowicz: Medical Faculty, Lodz Medical University, 90-647 Lodz, Poland
Hubert Szweda: Medical Physics Department, Greater Poland Cancer Centre, 61-866 Poznan, Poland
Krzysztof Matuszewski: Medical Physics Department, Greater Poland Cancer Centre, 61-866 Poznan, Poland
Witold Cholewiński: Electroradiology Department, Poznan University of Medical Sciences, 61-866 Poznan, Poland

DOI: https://doi.org/10.3390/ph14080722
Journal volume & issue: Vol. 14, no. 8
p. 722

Abstract

Read online

According to the international societies’ recommendations, the 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography ([18F]FDG PET/CT) technique should not be used as the method of choice in brain tumour diagnosis. Therefore, the brain region can be omitted during standard [18F]FDG PET/CT scanning. We performed comprehensive literature research and analysed results from 14,222 brain and torso [18F]FDG PET/CT studies collected in 2010–2020. We found 131 clinically silent primary and metastatic brain tumours and 24 benign lesions. We concluded that the brain and torso [18F]FDG PET/CT study provides valuable data that may support therapeutic management by detecting clinically silent primary and metastatic brain tumours.

Published in Pharmaceuticals

ISSN: 1424-8247 (Online)
Publisher: MDPI AG
Country of publisher: Switzerland
LCC subjects: Medicine: Pharmacy and materia medica
Website: http://www.mdpi.com/journal/pharmaceuticals/

About the journal

Abstract

Keywords